Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by CorMedix Inc. on October 13, 2022. The filing details the voting results for four proposals submitted to holders of common stock, Series E Preferred Stock, and Series G Preferred Stock.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
The following proposals were voted upon and approved by stockholders:
- Proposal 1 (Election of Directors): Seven nominees were elected to the Board of Directors to serve until the 2023 annual meeting. All nominees received a plurality of votes cast, though significant broker non-votes (19,076,853) were recorded for each.
- Proposal 2 (Say-on-Pay): The advisory vote on executive compensation was approved with 8,041,682 votes FOR and 2,406,462 votes AGAINST.
- Proposal 3 (Stock Incentive Plan): Stockholders approved the amendment and restatement of the 2019 Omnibus Stock Incentive Plan with 8,110,236 votes FOR and 2,308,931 votes AGAINST.
- Proposal 4 (Auditor Ratification): The appointment of Friedman LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022, was ratified with 27,961,029 votes FOR and 1,579,888 votes AGAINST.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or discussion of risks and contingencies. It strictly reports the outcomes of the shareholder vote.
Investor Verification Checklist
- Verify the composition of the newly elected Board of Directors against the company's latest proxy statement.
- Review the specific terms of the amended 2019 Omnibus Stock Incentive Plan to understand potential dilution or equity grant limits.
- Confirm the engagement of Friedman LLP as the independent auditor for the fiscal year ending December 31, 2022.
- Note the high volume of broker non-votes (approx. 19 million) on director elections, which may indicate significant institutional holdings where brokers lacked discretionary voting power.